Analyst coverage – Vivesto

Thomas Nilsson

Thomas Nilsson

Read more

Oasmia Pharmaceutical AB – Analysguiden 211206

Swedish December 6, 2021

Dr Joseph Hedden

Oasmia Pharmaceutical AB – Q3 results update

English November 18, 2021

Oasmia Pharmaceutical AB – Q2 results update

English August 19, 2021

Oasmia Pharmaceutical AB – Cantrixil Phase I data published in peer-reviewed journal

English June 30, 2021

Oasmia Pharmaceutical AB – Inceptua to now commercialise Apealea® in the Nordics

English June 28, 2021

Oasmia Pharmaceutical AB – Q1 results update

Oasmia Pharmaceutical AB – In-licenses clinical-stage ovarian cancer drug

Oasmia Pharmaceutical AB – Phase Ib of docetaxel micellar in prostate cancer authorised

Klas Palin

Read more

October 21, 2021

Oasmia – ny partner i öst

Svenska September, 2021

English August 20, 2021

English May 28, 2021

Dr Sean Conway & Dr Jonas Peciulis

Read more